[2-(carbamoyloxymethyl)-2,3-dimethylpentyl] carbamate;[2-(carbamoyloxymethyl)-2,3-dimethyl-pentyl] carbamate;carbamic acid [2-(carbamoyloxymethyl)-2,3-dimethylpentyl] ester;carbamic acid [2-(carbamoyloxymethyl)-2,3-dimethyl-pentyl] ester;[2-(aminocarbonyloxymethyl)-2,3-dimethyl-pentyl] carbamate;64-55-1;1,3-PROPANEDIOL, 2-sec-BUTYL-2-METHYL-, DICARBAMATE;D01807;Dormate (TN);NSC163921;WLN: ZVO1X1&1OVZY2&1;Mebutamate (JAN/USAN);2-[(carbamoyloxy)methyl]-2,3-dimethylpentyl carbamate;Capla (TN);MEGA;1,3-Propanediol, 2-methyl-2-(1-methylpropyl)-, dicarbamate;2,2-Dicarbamyloxymethyl-3-methylpentane;2-Methyl-2-(1-methylpropyl)-1,3-propanediol dicarbamate;2-Methyl-2-sec-butyl-1,3-propanediol dicarbamate;2-sec-Butyl-2-methyl-1,3-propanediol dicarbamate;2-sec-Butyl-2-methyltrimethylene dicarbamate;4-03-00-00074 (Beilstein Handbook Reference);Axiten;BRN 1788226;Butatensin;Capla;Carbamic acid, 2-sec-butyl-2-methyltrimethylene ester;Carbuten;DEA No. 2800;Dicamoylmethtane;Dormate;EINECS 200-587-5;Encapla;Ipotensivo;Mebutamat;Mebutamate;Mebutamate [USAN:BAN:INN:JAN];Mebutamato [INN-Spanish];Mebutamatum [INN-Latin];Mebutina;Mioartrina;NO-Press;NSC 163921;Prean;Preminex;Sigmafon;Vallene;W 583;W-583
[2-(carbamoyloxymethyl)-2,3-dimethylpentyl] carbamate